Five Prime Therapeutics

company

About

FivePrime is a clinical-stage biotechnology company that develops treatments for cancers.

  • 101 - 250

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$45M
Industries
Biotechnology,Health Care,Medical,Therapeutics
Founded date
Jan 1, 2001
Number Of Employee
101 - 250
Operating Status
Active

FivePrime is dis­cov­er­ing and devel­op­ing novel ther­a­peu­tic pro­teins and anti­bod­ies by sys­tem­at­i­cally screen­ing all rel­e­vant pro­teins in the human body to find the best pro­tein for treat­ment of a given clin­i­cal indi­ca­tion. FivePrime’s Pro­Screen Engine enables the rapid pro­duc­tion and screen­ing of all ther­a­peu­ti­cally rel­e­vant pro­teins in medically-​​focused assays at the high­est qual­ity stan­dards in the indus­try. This pow­er­ful approach is the polar oppo­site of the industry’s tra­di­tional “one pro­tein at a time”. The Pro­Screen Engine com­prises the defin­i­tive pro­tein col­lec­tion and screen­ing process for bio­log­ics dis­cov­ery and is unprece­dented in its effi­ciency, qual­ity, and scale. In addi­tion to DBL Investors, investors include Domain Asso­ciates, Ver­sant Ven­tures, Kleiner Perkins Cau­field and Byers, Texas Pacific Group, Health­Cap, and Advanced Tech­nol­ogy Ventures.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$55M
Five Prime Therapeutics has raised a total of $55M in funding over 2 rounds. Their latest funding was raised on Apr 20, 2012 from a Private Equity(PE) round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 20, 2012 Private Equity(PE) $10M 1 Detail
Feb 8, 2005 Series Unknown $45M 3 Detail

Investments

Number of Investments
Number of Lead Investments
1
0
Five Prime Therapeutics has made 1 investments. Their most recent investment was on Sep 5, 2022, when Behaviol raised $3.20M.
Date Company Name
Round Money Raised Industry Lead Investor
Sep 5, 2022 Behaviol
Seed $3.20M Artificial Intelligence

Investors

Number of Lead Investors
Number of Investors
3
Five Prime Therapeutics is funded by 3 investors. Versant Ventures and TPG are the most recent investors.
Investor Name Lead Investor Funding Round
Versant Ventures Private Equity(PE)
TPG Series Unknown
Singapore Bio-Innovations Series Unknown